Cargando…

Clinical course of percutaneous cholecystostomies: A cross-sectional study

BACKGROUND: Although cholecystectomy is the standard treatment modality, it has been shown that perioperative mortality is approaching 19% in critical and elderly patients. Percutaneous cholecystostomy (PC) can be considered as a safer option with a significantly lower complication rate in these pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Er, Sadettin, Berkem, Hüseyin, Özden, Sabri, Birben, Birkan, Çetinkaya, Erdinç, Tez, Mesut, Yüksel, Bülent Cavit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103974/
https://www.ncbi.nlm.nih.gov/pubmed/32258074
http://dx.doi.org/10.12998/wjcc.v8.i6.1033
_version_ 1783512154491584512
author Er, Sadettin
Berkem, Hüseyin
Özden, Sabri
Birben, Birkan
Çetinkaya, Erdinç
Tez, Mesut
Yüksel, Bülent Cavit
author_facet Er, Sadettin
Berkem, Hüseyin
Özden, Sabri
Birben, Birkan
Çetinkaya, Erdinç
Tez, Mesut
Yüksel, Bülent Cavit
author_sort Er, Sadettin
collection PubMed
description BACKGROUND: Although cholecystectomy is the standard treatment modality, it has been shown that perioperative mortality is approaching 19% in critical and elderly patients. Percutaneous cholecystostomy (PC) can be considered as a safer option with a significantly lower complication rate in these patients. AIM: To assess the clinical course of acute cholecystitis (AC) in patients we treated with PC. METHODS: The study included 82 patients with Grade I, II or III AC according to the Tokyo Guidelines 2018 (TG18) and treated with PC. The patients’ demographic and clinical features, laboratory parameters, and radiological findings were retrospectively obtained from their medical records. RESULTS: Eighty-two patients, 45 (54.9%) were male, and the median age was 76 (35-98) years. According to TG18, 25 patients (30.5%) had Grade I, 34 (41.5%) Grade II, and 23 (28%) Grade III AC. The American Society of Anesthesiologists (ASA) physical status score was III or more in 78 patients (95.1%). The patients, who had been treated with PC, were divided into two groups: discharged patients and those who died in hospital. The groups statistically significantly differed only concerning the ASA score (P = 0.0001) and WBCC (P = 0.025). Two months after discharge, two patients (3%) were readmitted with AC, and the intervention was repeated. Nine of the discharged patients (13.6%) underwent interval open cholecystectomy or laparoscopic cholecystectomy (8/1) within six to eight weeks after PC. The median follow-up time of these patients was 128 (12-365) wk, and their median lifetime was 36 (1-332) wk. CONCLUSION: For high clinical success in AC treatment, PC is recommended for high-risk patients with moderate-severe AC according to TG18, elderly patients, and especially those with ASA scores of ≥ III. According to our results, PC, a safe, effective and minimally invasive treatment, should be preferred in cases suffering from AC with high risk of mortality associated with cholecystectomy.
format Online
Article
Text
id pubmed-7103974
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-71039742020-04-02 Clinical course of percutaneous cholecystostomies: A cross-sectional study Er, Sadettin Berkem, Hüseyin Özden, Sabri Birben, Birkan Çetinkaya, Erdinç Tez, Mesut Yüksel, Bülent Cavit World J Clin Cases Retrospective Study BACKGROUND: Although cholecystectomy is the standard treatment modality, it has been shown that perioperative mortality is approaching 19% in critical and elderly patients. Percutaneous cholecystostomy (PC) can be considered as a safer option with a significantly lower complication rate in these patients. AIM: To assess the clinical course of acute cholecystitis (AC) in patients we treated with PC. METHODS: The study included 82 patients with Grade I, II or III AC according to the Tokyo Guidelines 2018 (TG18) and treated with PC. The patients’ demographic and clinical features, laboratory parameters, and radiological findings were retrospectively obtained from their medical records. RESULTS: Eighty-two patients, 45 (54.9%) were male, and the median age was 76 (35-98) years. According to TG18, 25 patients (30.5%) had Grade I, 34 (41.5%) Grade II, and 23 (28%) Grade III AC. The American Society of Anesthesiologists (ASA) physical status score was III or more in 78 patients (95.1%). The patients, who had been treated with PC, were divided into two groups: discharged patients and those who died in hospital. The groups statistically significantly differed only concerning the ASA score (P = 0.0001) and WBCC (P = 0.025). Two months after discharge, two patients (3%) were readmitted with AC, and the intervention was repeated. Nine of the discharged patients (13.6%) underwent interval open cholecystectomy or laparoscopic cholecystectomy (8/1) within six to eight weeks after PC. The median follow-up time of these patients was 128 (12-365) wk, and their median lifetime was 36 (1-332) wk. CONCLUSION: For high clinical success in AC treatment, PC is recommended for high-risk patients with moderate-severe AC according to TG18, elderly patients, and especially those with ASA scores of ≥ III. According to our results, PC, a safe, effective and minimally invasive treatment, should be preferred in cases suffering from AC with high risk of mortality associated with cholecystectomy. Baishideng Publishing Group Inc 2020-03-26 2020-03-26 /pmc/articles/PMC7103974/ /pubmed/32258074 http://dx.doi.org/10.12998/wjcc.v8.i6.1033 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Retrospective Study
Er, Sadettin
Berkem, Hüseyin
Özden, Sabri
Birben, Birkan
Çetinkaya, Erdinç
Tez, Mesut
Yüksel, Bülent Cavit
Clinical course of percutaneous cholecystostomies: A cross-sectional study
title Clinical course of percutaneous cholecystostomies: A cross-sectional study
title_full Clinical course of percutaneous cholecystostomies: A cross-sectional study
title_fullStr Clinical course of percutaneous cholecystostomies: A cross-sectional study
title_full_unstemmed Clinical course of percutaneous cholecystostomies: A cross-sectional study
title_short Clinical course of percutaneous cholecystostomies: A cross-sectional study
title_sort clinical course of percutaneous cholecystostomies: a cross-sectional study
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103974/
https://www.ncbi.nlm.nih.gov/pubmed/32258074
http://dx.doi.org/10.12998/wjcc.v8.i6.1033
work_keys_str_mv AT ersadettin clinicalcourseofpercutaneouscholecystostomiesacrosssectionalstudy
AT berkemhuseyin clinicalcourseofpercutaneouscholecystostomiesacrosssectionalstudy
AT ozdensabri clinicalcourseofpercutaneouscholecystostomiesacrosssectionalstudy
AT birbenbirkan clinicalcourseofpercutaneouscholecystostomiesacrosssectionalstudy
AT cetinkayaerdinc clinicalcourseofpercutaneouscholecystostomiesacrosssectionalstudy
AT tezmesut clinicalcourseofpercutaneouscholecystostomiesacrosssectionalstudy
AT yukselbulentcavit clinicalcourseofpercutaneouscholecystostomiesacrosssectionalstudy